viernes, 20 de febrero de 2026

FDA’s Top Drug Regulator To Examine Safety Of SSRIs And RSV Monoclonals

FDA’s Top Drug Regulator To Examine Safety Of SSRIs And RSV Monoclonals Tracy Beth Høeg, the fifth director of the Center for Drug Evaluation and Research since last year, says she is prioritizing the health of women and babies. Meanwhile, ACIP is postponing its meeting set for next week. Plus, measles cases continue to spread. https://kffhealthnews.org/morning-breakout/fdas-top-drug-regulator-to-examine-safety-of-ssris-and-rsv-monoclonals/

No hay comentarios: